Mark McGovern

Mark McGovern has extensive experience in clinical operations and research in the biopharmaceutical industry. Mark is currently serving as the Vice President of Clinical Operations at Eidos Therapeutics, a position they have held since July 2022. Prior to this role, they were a Senior Director of Clinical Operations at Eidos Therapeutics from April 2020 to July 2022.

Before joining Eidos Therapeutics, Mark worked as the Director of Clinical Operations at Antiva Bioscience from April 2016 to March 2020. Mark also served as an Associate Director of Clinical Operations and a Clinical Program Manager at Theravance Biopharma, Inc. from June 2013 to April 2016.

Mark has held various clinical development and research positions at Janssen Alzheimer Immunotherapy Research and Development, Baxter BioScience, InterMune, Elan Pharmaceuticals, Nuvelo, Peninsula Pharmaceuticals, and FibroGen, Inc. These roles include Manager of Clinical Development, Clinical Consultant, Clinical Program Consultant, and Senior Clinical Research Associate.

Overall, Mark McGovern has a strong background in clinical operations and research within the biopharmaceutical industry, with experience at multiple companies throughout their career.

Mark McGovern obtained their Bachelor of Science in Nursing (BSN) from Holy Family University between the years 1984 and 1987.